Kyu Sic You
4PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 12, 2025
JAK2 Inhibition Augments the Anti-Proliferation Effects by AKT and MEK Inhibition in Triple-Negative Breast Cancer Cells.Kyu Sic You, Tae-Sung Kim, Su Min Back
|Nov 11, 2022
Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells.Yong Weon Yi, Kyu Sic You, Sanghee Han
|Jul 02, 2021
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer.Kyu Sic You, Yong Weon Yi, Jeonghee Cho
|Apr 03, 2021
Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells.Kyu Sic You, Yong Weon Yi, Jeonghee Cho
Pageof 1
